Drug class in one race
Complement C5 drugs for Age-Related Macular Degeneration
3 tracked Complement C5 drugs in the Age-Related Macular Degeneration race. The class explanation lives on the Complement C5 page; the full indication pipeline across every mechanism is on the Age-Related Macular Degeneration page.
1 approved / phase 41 Phase 31 Phase 1/2
Head-to-head evidence: ABBV-6628 vs Avacincaptad pegol · Avacincaptad pegol vs Cemdisiran